Cargando…
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
According to common beliefs, conventional anticancer chemotherapy is deleterious for the immune system. We have recently provided in vitro evidence indicating that conventional chemotherapy may potentiate, rather than impair, the long-term efficacy of γδ T cell-based anticancer immunotherapy.
Autores principales: | Todaro, Matilde, Meraviglia, Serena, Caccamo, Nadia, Stassi, Giorgio, Dieli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825724/ https://www.ncbi.nlm.nih.gov/pubmed/24244907 http://dx.doi.org/10.4161/onci.25821 |
Ejemplares similares
-
Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes
por: Dieli, Francesco, et al.
Publicado: (2013) -
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity
por: Todaro, Matilde, et al.
Publicado: (2013) -
IL-21 Regulates the Differentiation of a Human γδ T Cell Subset Equipped with B Cell Helper Activity
por: Caccamo, Nadia, et al.
Publicado: (2012) -
Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
por: Cordova, Adriana, et al.
Publicado: (2012) -
Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)